24 reports

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Gastric Cancer
  • France
  • United States
  • World
  • Forecast
  • CAUSES OF GASTRIC CANCER
  • Gastric cancer drugs market in Japan

PART ##: Disease overview TYPES OF GASTRIC CANCER Gastric cancer is one of the common types of cancer.

  • Gastric Cancer
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Gastric Cancer, Stage Grouping
  • Pipeline for Gastric Cancer, Global, 2016

Gastric Breast Cancer; ##(##): ##-## Sakuramoto S, et al. (2007).

  • Gastric Cancer
  • Monoclonal Antibody
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Gastric cancer

4385 5000 3900
  • Marketed Drugs: Gastric Cancer
  • FORECAST: GASTRIC CANCER

Gastric Cancer, ##(##), ##-## < PMID> ##< / PMID>.

  • Gastric Cancer
  • East Asia
  • Japan
  • United States
  • Eli Lilly & Co.

Gastric Cancer Forecast and Market Analysis to 2024 FORECAST: GASTRIC CANCER (Published on ## December 2017) EXECUTIVE SUMMARY RECENT FORECAST UPDATES MARKET DYNAMICS FORECAST AND FUTURE TRENDS MARKET DEFINITION AND METHODOLOGY PRIMARY RESEARCH METHODOLOGY BIBLIOG

  • Cancer
  • Gastric Cancer
  • European Union
  • Japan
  • United States

Europe Gastric Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Gastric Cancer
  • Europe
  • France
  • Germany
  • Forecast

Gastric Cancer Drugs - R& D, Trends and Market Forecasts 2016-2026 ##.

  • Cancer
  • Gastric Cancer
  • Therapy
  • World
  • Market Size

Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets CHAPTER ## INTRODUCTION ## STUDY GOALS AND OBJECTIVES ## REASONS FOR DOING THE STUDY ## SCOPE AND FORMAT ## INTENDED AUDIENCE ## METHODOLOGY ## RELATED BCC RESEARCH REPORTS ## ANALYST' S CREDENTI

  • Cancer
  • Gastric Cancer
  • Pathology
  • Therapy
  • World

Drug analysis: Napabucasin Product Profiles BBI## : Gastric cancer napabucasin : Colorectal cancer (CRC) napabucasin : Non-small cell lung cancer (NSCLC) LIST OF FIGURES Figure ##: BBI## for gastric cancer – SWOT analysis Figure ##: Dat

  • Colorectal Cancer
  • Gastric Cancer
  • European Union
  • Japan
  • United States

Natalie Sacks to its Board of Directors ## Jul ##, 2017: Athenex, Announces Commencement of Patient Enrollment for Oraxol-plus-Ramucirumab Phase ##b Clinical Trial in Gastric Cancer ## Jul ##, 2017: Five Prime Therapeutics Initiates Patient Dosing in Phase ## Clinical Safety

  • Clinical Trial
  • Gastric Cancer
  • Pharmaceutical
  • Therapy
  • World

Similarly, the Universities portfolio in Phase II, Phase I, IND/ CTA Filed, Preclinical and Discovery stages comprises ##, ##, ##, ## and ## molecules, respectively.

  • Gastric Cancer
  • Pharmaceutical
  • Therapy
  • China

Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach.

  • Gastric Cancer
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • DIFFERENT TYPES OF GASTRIC CANCER
  • 5.2 GLOBAL GASTRIC CANCER MARKET

Pylori, one of the major causes of stomach cancer.

  • Gastric Cancer
  • United States
  • World
  • Market Size
  • Merck & Co., Inc.

Gastric Cancer Global Clinical Trials Review, H##, 2016 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributing to Clinical Trials in As

  • Clinical Trial
  • Gastric Cancer
  • Pharmaceutical
  • Therapy
  • World
  • JUN 19, 2017: THE US FDA GRANTS APATINIB ORPHAN DRUG DESIGNATION FOR TREATMENT OF GASTRIC CANCER
  • MAR 13, 2017: LSK BIOPHARMA ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 3 APATINIB TRIAL IN GASTRIC CANCER

Apatinib is indicated in treatment for metastatic gastric cancer.

  • Colorectal Cancer
  • Gastric Cancer
  • Therapy
  • United States
  • Product Initiative
  • Jun 19, 2017: The US FDA Grants Apatinib Orphan Drug Designation for Treatment of Gastric Cancer
  • apatinib mesylate

Apatinib is indicated in treatment for metastatic gastric cancer.

  • Gastric Cancer
  • Laboratory
  • Therapy
  • United States
  • Product Initiative
  • Gastric Cancer, Pipeline by Molecular Targets and
  • With regards to gastric cancer, the most influential

Gastric Breast Cancer; ##(##): ##-##.

  • Cancer
  • Gastric Cancer
  • Pathology
  • Therapy
  • Deals & Alliance
  • Jun 12, 2017: Aslan Pharmaceuticals Announces MTD For Varlitinib In Combination With Chemotherapies Commonly Used In First Line Gastric Cancer
  • 08/10/2018: ASLAN Pharmaceuticals completes recruitment for global phase 2 study for Varlitinib in first line gastric cancer

Gastric cancer currently ranks fourth in cancer incidence worldwide and is one of the most common types of cancer in Asia.

  • Gastric Cancer
  • China
  • United States
  • World
  • ASLAN Pharmaceuticals Pte Ltd.
  • Jun 12, 2017: Aslan Pharmaceuticals Announces MTD For Varlitinib In Combination With Chemotherapies Commonly Used In First Line Gastric Cancer
  • Jun 01, 2017: Aslan Pharmaceuticals Receives Clinical Trial Authorisation To Initiate Pivotal Study Of Varlitinib In Gastric Cancer

Gastric cancer currently ranks fourth in cancer incidence worldwide and is one of the most common types of cancer in Asia.

  • Gastric Cancer
  • China
  • United States
  • World
  • ASLAN Pharmaceuticals Pte Ltd.
  • GASTRIC CANCER
  • GASTRIC CANCER

GASTRIC CANCER CURRENTLY RANKS FOURTH IN CANCER INCIDENCE WORLDWIDE AND IS ONE OF THE MOST COMMON TYPES OF CANCER IN ASIA.

  • Cancer
  • Gastric Cancer
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Clinical Trial profile. 233 Trial Title
  • Clinical Trial profile. 40 Trial Title

A total of ## patients were enrolled in the study, including ## with breast cancer, ## with gastric, gastroesophageal junction, or esophageal (GE) cancer, and ## with other HER##-expressing cancers.

  • Chemotherapy
  • Gastric Cancer
  • Therapy
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 113 Trial Title

The prominent features of this report are - ##.

  • Gastric Cancer
  • Therapy
  • World
  • Product Initiative
  • Novartis AG
  • DIAGNOSTIC TEST - GASTRIC CANCER
  • DIAGNOSTIC TEST - GASTRIC CANCER - PRODUCT DESCRIPTION

Clinical Trials by Trial Status Trial Status No of Clinical Trials Colorectal Cancer ## Coronary Artery Disease ## Diabetes Mellitus ## Gastric Cancer ## Pancreatic Cancer ## Preeclampsia ## Prostate Cancer

  • Colorectal Cancer
  • Diabetes
  • Gastric Cancer
  • Pharmacy
  • Miraculins Inc.
  • PROGNOSTIC ASSAY - GASTRIC CANCER
  • DIAGNOSTIC ASSAY - GASTRIC CANCER

Global Inactive Class II Diagnostic Assay - Gastric Cancer - Product Description Indication Application Function Product Description Source: Primary / Secondary Research, GlobalData Gastric Cancer Diagnosis Of Gastric Cancer Detects

  • Gastric Cancer
  • Genomics
  • Spain
  • Company
  • Oryzon Genomics S.A.